Download
12888_2024_Article_6188.pdf 1,30MB
WeightNameValue
1000 Titel
  • Influence of inpatient withdrawal treatment on drug safety in alcohol use disorder — a quasi-experimental pre-post study
1000 Autor/in
  1. Schröder, Sebastian |
  2. Schulze Westhoff, Martin |
  3. Bleich, Stefan |
  4. Bode, Henry |
  5. Jendretzky, Konstantin Fritz |
  6. Krichevsky, Benjamin |
  7. Glahn, Alexander |
  8. Heck, Johannes |
1000 Verlag BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-10-25
1000 Erschienen in
1000 Quellenangabe
  • 24(1):733
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12888-024-06188-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11515795/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Objective</jats:title> <jats:p>Most patients with alcohol use disorder (AUD) regularly take medication. Alcohol interacts negatively with many commonly prescribed medications. Little is known about whether the risk of potential alcohol-medication and drug-drug interactions increases or decreases in patients with AUD during inpatient withdrawal treatment. The aim of our study was to determine the prevalence and characteristics of potential alcohol-medication and drug-drug interactions in patients with AUD before and after withdrawal treatment in an addiction unit.</jats:p> </jats:sec><jats:sec> <jats:title>Design</jats:title> <jats:p>Prospective monocentric quasi-experimental pre-post study.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>Medication records before and after withdrawal treatment were analyzed and screened for potential alcohol-medication (pAMI) and drug-drug interactions (pDDI) using the drugs.com classification and the AiD<jats:italic>Klinik</jats:italic><jats:sup>®</jats:sup> electronic interaction program, respectively.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>We enrolled 153 patients with AUD who were treated in an addiction unit of a university hospital in Germany. Of these, 67.3% experienced at least one pAMI before and 91.5% after withdrawal treatment. In total, there were 278 pAMIs classified as “mild,” “moderate,” or “severe” before and 370 pAMIs after withdrawal treatment. Additionally, there were 76 pDDIs classified as “moderate,” “severe,” or “contraindicated combinations” both before and after withdrawal treatment.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>The risk of exposure to pAMIs and pDDIs increases during inpatient withdrawal treatment in patients with AUD. Improvements in the quality of prescribing should particularly focus on the use of antihypertensives and opioids.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Female [MeSH]
lokal Aged [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Drug safety
lokal Middle Aged [MeSH]
lokal Substance abuse and comorbid psychiatric disorders
lokal Substance Withdrawal Syndrome [MeSH]
lokal Alcohol–medication interactions
lokal Male [MeSH]
lokal Drug–drug interactions
lokal Research
lokal Germany [MeSH]
lokal Drug Interactions [MeSH]
lokal Alcohol use disorder
lokal Potentially inappropriate medications
lokal Alcoholism/drug therapy [MeSH]
lokal Inpatients [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-0905-274X|https://orcid.org/0000-0003-3262-8137|https://orcid.org/0000-0001-5004-3824|https://orcid.org/0000-0002-7515-6996|https://frl.publisso.de/adhoc/uri/SmVuZHJldHpreSwgS29uc3RhbnRpbiBGcml0eg==|https://frl.publisso.de/adhoc/uri/S3JpY2hldnNreSwgQmVuamFtaW4=|https://frl.publisso.de/adhoc/uri/R2xhaG4sIEFsZXhhbmRlcg==|https://frl.publisso.de/adhoc/uri/SGVjaywgSm9oYW5uZXM=
1000 Hinweis
  • DeepGreen-ID: 97ab273d8f5b49f98b07a0a3697b1bf0 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search) ; at least one of the mandatory fields 'given-names' and 'family-name' is missing for the ORCID profile of 'Heck, Johannes' (https://orcid.org/0000-0002-5382-3014)
1000 Label
1000 Förderer
  1. Medizinische Hochschule Hannover (MHH) |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Medizinische Hochschule Hannover (MHH) |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6490494.rdf
1000 Erstellt am 2025-02-03T11:32:00.584+0100
1000 Erstellt von 322
1000 beschreibt frl:6490494
1000 Zuletzt bearbeitet 2025-09-14T05:57:26.168+0200
1000 Objekt bearb. Sun Sep 14 05:57:26 CEST 2025
1000 Vgl. frl:6490494
1000 Oai Id
  1. oai:frl.publisso.de:frl:6490494 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source